 |
市场调查报告书
商品编码
1608743
TCV 疫苗市场：依疫苗品牌、通路、地区划分TCV Vaccines Market, By Vaccine Brand (Ty21a (Vivotif), ViCPS (Typhim Vi), Vi-TT (Peda-typhTM), and Typbar TCV), By Distribution Channel (Public and Private), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa) |
||||||
TCV 疫苗市场预计 2024 年为 4.128 亿美元，预计 2031 年将达到 9.359 亿美元，2024 年至 2031 年复合年增长率为 12.4%。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年 | 2023年 | 2024年市场规模 | 4.128 亿美元 |
| 实际资料 | 2019-2023 | 预测期 | 2024年至2031年 |
| 预测 2024-2031 年复合年增长率： | 12.40% | 2031年价值预测 | 9.359 亿 |
近年来，由于疾病和感染疾病发生率的增加，TCV 疫苗市场稳步成长。 TCV 疫苗针对的是破伤风、白喉和百日咳，这些都是高度传染性的细菌性呼吸道疾病。百日咳对婴幼儿尤其危险，使其成为全球疫苗接种计画的关键驱动力。儘管世界各地破伤风和白喉疫苗接种率很高，但百日咳仍继续在学校和社区传播，需要常规疫苗接种。人们对疫苗接种益处的认识不断提高，以及政府为加强开发中国家的常规免疫计画所做的努力，正在推动市场收益的成长。最近的新产品核可和评估扩大适应症的大规模临床试验进一步扩大了该市场的成长机会。
市场动态：
由于新兴市场需求的增加和全球免疫计划的扩大，TCV 疫苗市场预计将继续稳定成长。推动市场的关键因素包括家长意识的提高、国际卫生组织越来越多地提出保护弱势群体的建议，以及低收入和中等收入国家的政府补贴和资金。然而，联合疫苗的研发、製造和分销相关的高成本对疫苗的使用构成了重大挑战。此外，由于错误讯息和宗教信仰而对疫苗犹豫不决正在阻碍一些国家的市场潜力。
本研究的主要特点
本报告对全球TCV疫苗市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031）的市场规模和年复合成长率（CAGR%）。
它还揭示了各个细分市场的潜在商机，并解释了该市场中有吸引力的投资提案的矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
全球 TCV 疫苗市场的主要企业概况根据公司亮点、产品系列、主要亮点、绩效和策略等参数列出。
主要企业包括 GSK plc.、赛诺菲、Bharat Biotech、BioFarma、Zydus Group、Emergent BioSolutions Inc.、Bavarian Nordic Inc.、Crucell Switzerland LTD.、PaxVax, Inc. 和 BIO-MED。
本报告中的见解将帮助负责人和公司经营团队就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
TCV 疫苗全球市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以透过用于分析全球 TCV 疫苗市场的各种策略矩阵来促进决策。
目录
第一章 研究目的与前提
- 研究目的
- 先决条件
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
第三章市场动态、法规及趋势分析
- 市场动态
- 影响分析
- 主要亮点
- 监管场景
- 产品发布/核准
- PEST分析
- 波特分析
- 併购场景
- 市场趋势
- 流行病学
第四章2019-2031年全球TCV疫苗市场（以疫苗品牌）
- Ty21a（Bibotif）
- ViCPS（伤寒 Vi）
- Vi-TT (PedatifuTM)
- 类型条 TCV
第五章全球 TCV 疫苗市场，依通路划分，2019-2031 年
- 公共
- 联合国儿童基金会
- 竞标（政府）
- 私人的
第六章2019-2031年全球TCV疫苗市场（按地区）
- 北美洲
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
- 非洲
第七章 竞争格局
- GSK plc.
- Sanofi
- Bharat Biotech
- BioFarma
- Zydus Group
- Emergent BioSolutions Inc.
- Bavarian Nordic Inc.
- Crucell Switzerland LTD.
- PaxVax, Inc.
- BIO-MED
第八章 分析师建议
- 命运之轮
- 分析师观点
- 一致的机会图
第9章 参考文献及调查方法
- 参考
- 调查方法
- 关于出版商
TCV vaccines market is estimated to be valued at USD 412.8 Mn in 2024 and is expected to reach USD 935.9 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 12.4% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | 412.8 Mn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 12.40% | 2031 Value Projection: | 935.9 Mn |
The TCV vaccines market has been witnessing steady growth over the past few years due to increasing incidence of diseases and infections. TCV vaccines target tetanus, diphtheria, and pertussis/whooping cough which are highly infectious bacterial respiratory diseases. Pertussis is especially dangerous for infants and young children which has been a key factor driving vaccination programs globally. While tetanus and diphtheria vaccination rates are high worldwide, pertussis continues to spread in schools and communities necessitating regular booster doses. Growing awareness about benefits of immunization and government efforts to strengthen routine immunization programs in developing countries have boosted market revenues. Recent new product approvals and large clinical trials evaluating expansion of indication have further widened growth opportunities in this market.
Market Dynamics:
TCV vaccines market is expected to witness robust growth going forward on account of rising demand from developing regions and increasing coverage of vaccination programs worldwide. The key drivers fueling the market include growing awareness among parents, expanding recommendation by international health organizations to protect vulnerable population groups, and government subsidies and funding in low and middle income nations. However, high costs associated with R&D, manufacturing, and distribution of combination vaccines pose a major challenge to adoption rates. In addition, ongoing vaccine hesitancy due to misinformation and religious beliefs inhibits market potential in some countries.
Key Features of the Study:
This report provides in-depth analysis of the global TCV vaccines market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global TCV vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GSK plc., Sanofi, Bharat Biotech, BioFarma, Zydus Group, Emergent BioSolutions Inc., Bavarian Nordic Inc., Crucell Switzerland LTD., PaxVax, Inc., and BIO-MED
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global TCV vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global TCV vaccines market
Market Segmentation
- By Vaccine Brand Insights (Revenue, USD Mn, 2019 - 2031)
- Ty21a (Vivotif)
- ViCPS (Typhim Vi)
- Vi-TT (Peda-typhTM)
- Typbar TCV
- By Distribution Channel Insights (Revenue, USD Mn, 2019 - 2031)
- Public
- UNICEF
- Tender (Govt.)
- Private
- Regional Insights (Revenue, USD Mn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- GSK plc.
- Sanofi
- Bharat Biotech
- BioFarma
- Zydus Group
- Emergent BioSolutions Inc.
- Bavarian Nordic Inc.
- Crucell Switzerland LTD.
- PaxVax, Inc.
- BIO-MED
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- TCV Vaccines Market, By Vaccine Brand
- TCV Vaccines Market, By Distribution Channel
- TCV Vaccines Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Market Trends
- Epidemiology
4. Global TCV Vaccines Market, By Vaccine Brand, 2019-2031, (USD Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Ty21a (Vivotif)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- ViCPS (Typhim Vi)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Vi-TT (Peda-typhTM)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Typbar TCV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
5. Global TCV Vaccines Market, By Distribution Channel, 2019-2031, (USD Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Public
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- UNICEF
- Tender (Govt.)
- Private
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
6. Global TCV Vaccines Market, By Region, 2019 - 2031, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
7. Competitive Landscape
- GSK plc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bharat Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BioFarma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Zydus Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Emergent BioSolutions Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bavarian Nordic Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Crucell Switzerland LTD.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PaxVax, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BIO-MED
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
8. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
9. References and Research Methodology
- References
- Research Methodology
- About us
人类狂犬病疫苗市场：按细胞株类型、给药途径、应用、分销管道 - 全球预测 2025-2030
兽用狂犬病疫苗市场、机会、成长动力、产业趋势分析与预测，2024-2032![狂犬病疫苗市场 - 按产品类型 [婴儿仓鼠肾 (BHK)、Vero 细胞狂犬病疫苗]、类型（人用、兽用）、应用（暴露前预防、暴露后预防）、配销通路、全球预测（2024 年- 2032 年）](/sample/img/cover/42/1535700.png)
狂犬病疫苗市场 - 按产品类型 [婴儿仓鼠肾 (BHK)、Vero 细胞狂犬病疫苗]、类型（人用、兽用）、应用（暴露前预防、暴露后预防）、配销通路、全球预测（2024 年- 2032 年）
狂犬病疫苗市场，按产品类型、应用、预防类型、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测
预防疫苗市场，按疫苗类型，按疾病类型，按配销通路，按地理
狂犬病疫苗市场：按产品类型、按预防类型、按应用、按最终用户：2023-2032 年全球机会分析和产业预测
狂犬病疫苗市场报告：2030 年趋势、预测与竞争分析
百日咳疫苗市场报告：2030 年趋势、预测与竞争分析
灭活脊髓灰质炎·狂犬病(恐水症)疫苗市场:疫苗，各灭活方法，各年龄层，各流通管道，各地区- 市场规模，占有率，展望，机会分析，2023年～2030年